Morning Market Losers By: Benzinga via Benzinga September 05, 2014 at 09:43 AM EDT Recro Pharma (NASDAQ: REPH) dipped 46.41% to $3.06 after the company reported that its trial study is not seen reaching statistical ... Read More >> Related Stocks: Finisar Corp Gap Golar Lng Ltd Golden Minerals Company Michael Kors Holdings Pennantpark Investme Recro Pharma Inc Zumiez Inc